OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.890
-0.110 (-5.50%)
At close: Mar 6, 2026, 4:00 PM EST
1.860
-0.030 (-1.59%)
After-hours: Mar 6, 2026, 6:35 PM EST
OmniAb Market Cap
OmniAb has a market cap or net worth of $273.64 million as of March 6, 2026. Its market cap has decreased by -38.39% in one year.
Market Cap
273.64M
Enterprise Value
239.95M
1-Year Change
-38.39%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $273.64M, a decrease of -72.44%. That is a compound annual growth rate of -31.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 289.57M | 8.73% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 273.58M |
| Enlivex | 272.99M |
| Cybin | 272.70M |
| Coherus Oncology | 271.29M |
| Prelude Therapeutics | 267.79M |
| Abeona Therapeutics | 265.27M |
| Cellectis | 265.08M |
| Fennec Pharmaceuticals | 263.32M |